EGF Prevents the Neuroendocrine Differentiation of LNCaP Cells Induced By Serum Deprivation: The Modulator Role of P13K/Akt

The primary focus of this investigation was to study the relationship between neuroendocrine (NE) differentiation, epidermal growth factor (EGF) because both have been implicated in the progression of prostate cancer. For this purpose, we used gefitinib, trastuzumab, which are inhibitors of EGF rece...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Rosa M. Martín-Orozco, Carmen Almaraz-Pro, F. Javier Rodríguez-Ubreva, M. Alicia Cortés, Santiago Ropero, Ramon Colomer, Pilar López-Ruiz, Begona Colás
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2007-08-01
Reeks:	Neoplasia: An International Journal for Oncology Research
Onderwerpen:	EGF prostate cancer neuroendocrine differentiation gefinitib trastuzu mab
Online toegang:	http://www.sciencedirect.com/science/article/pii/S1476558607800686
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!